Symptom Burden In Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)

被引：0
|
作者：
Williams, Loretta A.
Ault, Patricia S.
Kantarjian, Hagop M.
Garcia-Manero, Guillermo
Quintas-Cardama, Alfonso
Borthakur, Gautam
Faderl, Stefan H.
Jabbour, Elias J.
Cleeland, Charles S.
Cortes, Jorge E.
机构：
来源：
BLOOD | 2013年 / 122卷 / 21期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2988
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Comparison of Symptom Burden in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
    Williams, Loretta A.
    Ahaneku, Hycienth
    Cortes, Jorge E.
    Manero, Guillermo Garcia
    Kantarjian, Hagop M.
    Shi, Qiuling
    Lin, Huei-Kai
    Limaye, Achala R.
    Cleeland, Charles S.
    BLOOD, 2014, 124 (21)
  • [2] A Patient-Reported Outcome Measure for Symptoms and Symptom Burden of Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
    Williams, Loretta A.
    Garcia-Gonzalez, Araceli
    Ahaneku, Hycienth O.
    Cortes, Jorge E.
    Garcia-Manero, Guillermo
    Kantarjian, Hagop M.
    Mendoza, Tito R.
    Shi, Qiuling
    Borthakur, Gautam
    Burger, Jan A.
    Jabbour, Elias J.
    Takahashi, Koichi
    Lin, Huei K.
    Limaye, Achala
    Cleeland, Charles S.
    BLOOD, 2015, 126 (23)
  • [3] A PATIENT-REPORTED OUTCOME MEASURE FOR SYMPTOMS AND SYMPTOM BURDEN OF ACUTE MYELOID LEUKEMIA (AML) AND MYELODYSPLASTIC SYNDROME (MDS).
    Williams, Loretta A.
    Gonzalez, Araceli Garcia
    Cortes, Jorge E.
    Garcia-Manero, Guillermo
    Mendoza, Tito R.
    Cleeland, Charles S.
    ONCOLOGY NURSING FORUM, 2016, 43 (02) : 59 - 60
  • [4] Myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML) in Down syndrome: Pathologic aspects
    Mast, K.
    Taub, J. W.
    Alonzo, T.
    Mosse, C.
    Gamis, A. S.
    Mathew, P.
    Jones, H.
    Hitzler, J.
    Head, D. R.
    LEUKEMIA RESEARCH, 2013, 37 : S89 - S90
  • [5] Diagnostic of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)
    Germing, Ulrich
    Haferlach, Torsten
    LABORATORIUMSMEDIZIN-JOURNAL OF LABORATORY MEDICINE, 2015, 39 (05): : 291 - 299
  • [6] Erythropoietin (EPO)-dependent transformation of myelodysplastic syndrome (MDS) to acute myeloid leukemia (AML).
    Bunworasate, U
    Arnouk, H
    Minderman, H
    O'Loughlin, KL
    Sait, SNJ
    Barcos, M
    Baer, MR
    BLOOD, 2000, 96 (11) : 259B - 259B
  • [7] The development of pevonedistat in myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML): hope or hype?
    Snow, Anson
    Zeidner, Joshua F.
    THERAPEUTIC ADVANCES IN HEMATOLOGY, 2022, 13
  • [8] Acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) following treatment for ovarian cancer
    Gupta, B.
    Sait, S. N.
    Block, A. W.
    Ford, L. A.
    Moysich, K. B.
    Baer, M. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [9] CONNECT MDS AND AML: THE MYELODYSPLASTIC SYNDROMES (MDS) AND ACUTE MYELOID LEUKEMIA (AML) DISEASE REGISTRY
    Steensma, D.
    Abedi, M.
    Bejar, R.
    Cogle, C.
    Foucar, K.
    Garcia-Manero, G.
    George, T.
    Grinblatt, D.
    Komrokji, R.
    Maciejewski, J.
    Pollyea, D.
    Roboz, G.
    Savona, M.
    Scott, B.
    Sekeres, M.
    Thompson, M.
    Sugrue, M.
    Swern, A.
    Nifenecker, M.
    Erba, H.
    LEUKEMIA RESEARCH, 2015, 39 : S124 - S124
  • [10] Acquired chromosomal aberrations in children with Down syndrome and myelodysplastic syndrome (MDS) or acute myeloid leukemia (AML)
    Teigler-Schlegel, A
    Baumann, I
    Creutzig, U
    Niemeyer, C
    Harbott, J
    LEUKEMIA, 2000, 14 (05) : 966 - 966
12345